| 1 |
The proximal origin of SARS-CoV-2
Kristian G. Andersen, Andrew Rambaut, Walter Ian Lipkin et al. · Nature Medicine
Open access |
17 Mar 2020 |
5,518 |
| 2 |
Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
John S. Schieffelin et al. · New England Journal of Medicine
Open access |
29 Oct 2014 |
537 |
| 3 |
The origins of SARS-CoV-2: A critical review
Edward Charles Holmes et al. · Cell
Open access |
19 Aug 2021 |
519 |
| 4 |
The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic
Michael Worobey, Joshua I. Levy, Lorena M. Malpica Serrano et al. · Science
Open access |
26 Jul 2022 |
457 |
| 5 |
Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus
Kristian G. Andersen et al. · Cell
Open access |
Aug 2015 |
330 |
| 6 |
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
Jonathan E. Pekar et al. · Science
Open access |
26 Jul 2022 |
258 |
| 7 |
Lassa Fever in Post-Conflict Sierra Leone
Jeffrey G. Shaffer et al. · PLoS neglected tropical diseases
Open access |
20 Mar 2014 |
250 |
| 8 |
Structural basis for antibody-mediated neutralization of Lassa virus
Kathryn M. Hastie, Michelle A. Zandonatti, Lara M. Kleinfelter et al. · Science
Open access |
2 Jun 2017 |
234 |
| 9 |
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
James E. Robinson et al. · Nature Communications
Open access |
10 May 2016 |
185 |
| 10 |
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time
Kayla G. Barnes et al. · Nature Communications
Open access |
17 Aug 2020 |
184 |
| 11 |
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
Chad E. Mire, Robert W. Cross, Joan B. Geisbert et al. · Nature Medicine
Open access |
4 Sep 2017 |
147 |
| 12 |
Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever
Giovanni Lo Iacono, Andrew A. Cunningham, Élisabeth Fichet-Calvet et al. · PLoS neglected tropical diseases
Open access |
8 Jan 2015 |
130 |
| 13 |
Retinoic acid degradation shapes zonal development of vestibular organs and sensitivity to transient linear accelerations
Kazuya Ono, James E. Keller, Omar López et al. · Nature Communications
Open access |
2 Jan 2020 |
105 |
| 14 |
Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades
Raphaëlle Klitting et al. · Nature Communications
Open access |
27 Sep 2022 |
95 |
| 15 |
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
Soumya Jaganathan, Francis Stieber, Sonia N. Rao et al. · Infectious Diseases and Therapy
Open access |
25 Aug 2021 |
81 |
| 16 |
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies
Robert W. Cross, Chad E. Mire, Luis M. Branco et al. · Antiviral Research
Open access |
15 Aug 2016 |
78 |
| 17 |
Analysis of CD8 + T cell response during the 2013–2016 Ebola epidemic in West Africa
Saori Sakabe, Brian Martin Sullivan, Jessica N. Hartnett et al. · Proceedings of the National Academy of Sciences
Open access |
23 Jul 2018 |
68 |
| 18 |
Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice
Vandana Kalia, Yevgeniy Yuzefpolskiy, Adithya Vegaraju et al. · Science Translational Medicine
Open access |
13 Oct 2021 |
67 |
| 19 |
Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization
Kathryn M. Hastie, Robert W. Cross, Stephanie S. Harkins et al. · Cell
Open access |
Aug 2019 |
59 |
| 20 |
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
Matthew L. Boisen et al. · Scientific Reports
Open access |
11 Apr 2018 |
56 |
| 21 |
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
Robert W. Cross et al. · The Journal of Infectious Diseases
Open access |
31 Aug 2016 |
53 |
| 22 |
Emergence of an early SARS-CoV-2 epidemic in the United States
Mark Zeller et al. · Cell
Open access |
27 Jul 2021 |
52 |
| 23 |
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
Jacob C. Milligan et al. · Cell
Open access |
Mar 2022 |
50 |
| 24 |
Antibody therapy for Lassa fever
Robert W. Cross, Kathryn M. Hastie, Chad E. Mire et al. · Current Opinion in Virology
ReviewOpen access |
Aug 2019 |
47 |
| 25 |
Ebola Virus Delta Peptide Is a Viroporin
Jing He, Lilia I. Melnik, Alexander Komin et al. · Journal of Virology
Open access |
25 May 2017 |
44 |
| 26 |
Multiple Circulating Infections Can Mimic the Early Stages of Viral Hemorrhagic Fevers and Possible Human Exposure to Filoviruses in Sierra Leone Prior to the 2014 Outbreak
Matthew L. Boisen et al. · Viral Immunology
Open access |
22 Dec 2014 |
44 |
| 27 |
Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies
Adrian S. Enriquez, Tierra K. Buck, Haoyang Li et al. · Cell Reports
Open access |
May 2022 |
41 |
| 28 |
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans
Rodrigo Borrega et al. · Viruses
Open access |
21 Nov 2021 |
40 |
| 29 |
Multiplexing siRNAs to compress RNAi-based screen size in human cells
Scott E. Martin, Tamara L. Jones, Cheryl L. Thomas et al. · Nucleic Acids Research
Open access |
29 Mar 2007 |
40 |
| 30 |
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
Matthew L. Boisen et al. · Scientific Reports
Open access |
26 May 2020 |
39 |
| 31 |
High crossreactivity of human T cell responses between Lassa virus lineages
Brian Martin Sullivan et al. · PLoS Pathogens
Open access |
6 Mar 2020 |
38 |
| 32 |
An Outbreak of Ebola Virus Disease in the Lassa Fever Zone
Augustine Goba et al. · The Journal of Infectious Diseases
Open access |
11 Jul 2016 |
38 |
| 33 |
Epidemiology and Management of the 2013–16 West African Ebola Outbreak
Matthew L. Boisen, Jessica N. Hartnett, Augustine Goba et al. · Annual Review of Virology
ReviewOpen access |
19 Aug 2016 |
38 |
| 34 |
Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali
Nafomon Sogoba, Kyle Rosenke, Jennifer Adjemian et al. · Emerging infectious diseases
Open access |
Mar 2016 |
38 |
| 35 |
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
Matthew L. Boisen et al. · The Journal of Infectious Diseases
Open access |
11 Aug 2016 |
37 |
| 36 |
Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail
Arnaud C. Drouin, Marc Theberge, Sharon Y. Liu et al. · Viruses
Open access |
23 Jun 2021 |
37 |
| 37 |
Smoking Induces Overexpression of Immediate Early Genes in Active Graves' Ophthalmopathy
Tereza Planck, Bushra Shahida, Hemang M. Parikh et al. · Thyroid
|
19 Aug 2014 |
37 |
| 38 |
A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
Robert W. Cross, Megan L. Heinrich, Karla A. Fenton et al. · Proceedings of the National Academy of Sciences
Open access |
17 Aug 2023 |
36 |
| 39 |
Development of Prototype Filovirus Recombinant Antigen Immunoassays
Matthew L. Boisen et al. · The Journal of Infectious Diseases
Open access |
30 Jul 2015 |
36 |
| 40 |
The Arenaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens
Kathryn M. Hastie, Lilia I. Melnik, Robert W. Cross et al. · The Journal of Infectious Diseases
Open access |
15 Oct 2023 |
34 |
| 41 |
Vectorborne Infections, Mali
David Safronetz, Moussa Sacko, Nafomon Sogoba et al. · Emerging infectious diseases
Open access |
4 Jan 2016 |
34 |
| 42 |
Technical note: Bone DNA extraction and purification using silica‐coated paramagnetic beads
Mary Jones Dukes, Audra L. Williams, Corina M. Massey et al. · American Journal of Physical Anthropology
|
28 Mar 2012 |
33 |
| 43 |
The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade
Robert F. Garry · Proceedings of the National Academy of Sciences
Open access |
10 Nov 2022 |
32 |
| 44 |
Programming of CD8 T Cell Quantity and Polyfunctionality by Direct IL-1 Signals
Surojit Sarkar, Yevgeniy Yuzefpolskiy, Hanxi Xiao et al. · The Journal of Immunology
|
19 Nov 2018 |
32 |
| 45 |
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial
Scott Michael Norberg, Janet Valdez, Scott Napier et al. · The Lancet Respiratory Medicine
Open access |
21 Jan 2025 |
28 |
| 46 |
SARS-CoV-2 furin cleavage site was not engineered
Robert F. Garry · Proceedings of the National Academy of Sciences
Open access |
29 Sep 2022 |
28 |
| 47 |
Neutralizing Antibodies against Lassa Virus Lineage I
Tierra K. Buck, Adrian S. Enriquez, Sharon L. Schendel et al. · mBio
Open access |
22 Jun 2022 |
28 |
| 48 |
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
Megan L. Heinrich et al. · Scientific Reports
Open access |
29 Sep 2020 |
28 |
| 49 |
The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis
Scott Michael Norberg, Ke Bai, Cem M. Sievers et al. · Science Translational Medicine
Open access |
25 Oct 2023 |
27 |
| 50 |
Identification of Common CD8+T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone
Saori Sakabe et al. · Journal of Virology
Open access |
6 Apr 2020 |
27 |